检索结果 - Mauro Zucchetto
- Showing 1 - 2 results of 2
-
1
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial 由 Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Bridget K. Wagner, Mauro Zucchetto, Ganesh Raghu, Fernando J. Martínez, Jonathan Goldin, Jeffrey Siegel, Christopher P. Denton
出版 2021Artigo -
2
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis 由 Hermine I. Brunner, Nicolino Ruperto, Athimalaipet V Ramanan, Gerd Horneff, Kirsten Minden, Inmaculada Calvo Penadés, Е.I. Alexeeva, Gavin Cleary, Sara Stern, Isabelle Koné‐Paut, María del Rocío Maldonado Velázquez, C. Egla Rabinovich, Agustín Remesal, Clóvis A. Silva, И. П. Никишина, Mauro Zucchetto, Laura Brockwell, Oliver Gordon, Sandra Nagel, Fabrizio De Benedetti, Rubén Cuttica, Maria Elena Rama, Jonathan Akikusa, Jeffrey Chaitow, Cláudio Arnaldo Len, Clóvis A. Silva, Heinrike Schmeling, Rayfel Schneider, Isabelle Koné‐Paut, Markus Hufnagel, Kirsten Minden, Gerd Horneff, Fabrizio De Benedetti, María del Rocío Maldonado Velázquez, Nadina Rubio, Е. И. Алексеева, Agustín Remesal, Alina Boteanu, Rosa Bou, Inmaculada Calvo Penadés, Athimalaipet V Ramanan, Gavin Cleary, Hermine I. Brunner, Ginger Janow, Jennifer E. Weiss, Daniel J. Lovell, Alan Martin, Kabita Nanda, Linda Wagner‐Weiner, Sara Stern, Andrew Zeft, Jason Dare
出版 2024Artigo